• Login
    View Item 
    •   Home
    • The Christie Research Publications Repository
    • All Christie Publications
    • View Item
    •   Home
    • The Christie Research Publications Repository
    • All Christie Publications
    • View Item
    JavaScript is disabled for your browser. Some features of this site may not work without it.

    Browse

    All of ChristieCommunitiesTitleAuthorsIssue DateSubmit DateSubjectsThis CollectionTitleAuthorsIssue DateSubmit DateSubjectsProfilesView

    My Account

    LoginRegister

    Local Links

    The Christie WebsiteChristie Library and Knowledge Service

    Statistics

    Display statistics

    Impact of Oncotype DX Breast Recurrence Score testing on adjuvant chemotherapy use in early breast cancer: real world experience in Greater Manchester, UK.

    • CSV
    • RefMan
    • EndNote
    • BibTex
    • RefWorks
    Thumbnail
    Name:
    PIIS0748798317300379.pdf
    Size:
    346.4Kb
    Format:
    PDF
    Description:
    Full text, Open Access Article
    Download
    Authors
    Loncaster, Juliette A
    Armstrong, Anne C
    Howell, Sacha J
    Wilson, Gregory
    Welch, Richard
    Chittalia, Abbas
    Valentine, W
    Bundred, N
    Affiliation
    The Christie Hospital, Department of Medical Oncology, 550 Wilmslow Rd, Manchester, M20 4BX
    Issue Date
    2017-01-09
    
    Metadata
    Show full item record
    Abstract
    The National Institute for Health and Clinical Excellence (NICE) recommended the Oncotype DX(®) Breast Recurrence Score(®) (RS) assay as an option for informing adjuvant chemotherapy decisions in node-negative, oestrogen receptor (ER)+, human epidermal growth factor receptor 2 (HER2)-negative early breast cancer assessed to be at intermediate risk of recurrence based on clinicopathological factors. We evaluated the impact of RS testing on adjuvant chemotherapy decision-making in routine clinical practice in a UK Cancer Network.
    Citation
    Impact of Oncotype DX Breast Recurrence Score testing on adjuvant chemotherapy use in early breast cancer: real world experience in Greater Manchester, UK. 2017, Eur J Surg Oncol
    Journal
    European Journal of Surgical Oncology
    URI
    http://hdl.handle.net/10541/620175
    DOI
    10.1016/j.ejso.2016.12.010
    PubMed ID
    28111076
    Type
    Article
    Language
    en
    ISSN
    1532-2157
    ae974a485f413a2113503eed53cd6c53
    10.1016/j.ejso.2016.12.010
    Scopus Count
    Collections
    All Christie Publications

    entitlement

    Related articles

    • The impact of Oncotype DX breast cancer assay results on clinical practice: a UK experience.
    • Authors: Crolley VE, Marashi H, Rawther S, Sirohi B, Parton M, Graham J, Vinayan A, Sutherland S, Rigg A, Wadhawan A, Harper-Wynne C, Spurrell E, Bond H, Raja F, King J
    • Issue date: 2020 Apr
    • [Economic assessment of the routine use of Oncotype DX® assay for early breast cancer in Franche-Comte region].
    • Authors: Nerich V, Curtit E, Bazan F, Montcuquet P, Villanueva C, Chaigneau L, Cals L, Méneveau N, Dobi E, Altmotlak H, Algros MP, Choulot MJ, Nallet G, Limat S, Mansion S, Pivot X
    • Issue date: 2014 Jul-Aug
    • Association between partial-volume corrected SUVmax and Oncotype DX recurrence score in early-stage, ER-positive/HER2-negative invasive breast cancer.
    • Authors: Lee SH, Ha S, An HJ, Lee JS, Han W, Im SA, Ryu HS, Kim WH, Chang JM, Cho N, Moon WK, Cheon GJ
    • Issue date: 2016 Aug
    • Impact of the 21-gene recurrence score assay compared with standard clinicopathologic guidelines in adjuvant therapy selection for node-negative, estrogen receptor-positive breast cancer.
    • Authors: Partin JF, Mamounas EP
    • Issue date: 2011 Nov
    • Implications of the 21-gene recurrence score assay (Oncotype DX) on adjuvant treatment decisions in ER-positive early-stage breast cancer patients: experience of Kuwait Cancer Control Center.
    • Authors: Fayaz S, Eissa HE, Demian GA
    • Issue date: 2020 Mar 4
    DSpace software (copyright © 2002 - 2025)  DuraSpace
    Quick Guide | Contact Us
    Open Repository is a service operated by 
    Atmire NV
     

    Export search results

    The export option will allow you to export the current search results of the entered query to a file. Different formats are available for download. To export the items, click on the button corresponding with the preferred download format.

    By default, clicking on the export buttons will result in a download of the allowed maximum amount of items.

    To select a subset of the search results, click "Selective Export" button and make a selection of the items you want to export. The amount of items that can be exported at once is similarly restricted as the full export.

    After making a selection, click one of the export format buttons. The amount of items that will be exported is indicated in the bubble next to export format.